Overexpression of AKT1 in prostate cancer cells was shown to upregulate the CXCR4 expression and, therefore, promotes intraosseous tumor growth as well as the formation of metastases with an osteolytic phenotype. Here, CXCR4 is linked to prostate carcinoma.